[ad_1]
Health experts believe that the United States Food and Drug Administration (FDA) will issue an authorization for the use of the Pfizer vaccine for children under the age of 12.
“By Halloween we will see vaccinations for children, which will take several weeks before such a decision is made,” FDA consultant Dr. James Heldreth recently told CNN.
“Expanding access to a vaccine will be important in protecting children and ending the virus’s grip on the United States for all,” said Dr. Peter Hotez, dean of the National School of Medicine at Baylor College of Medicine.
Today with @BioNTech_Group, we are proud to announce the first positive results of the pivotal trial of our # COVID-19[FEMALE[FEMININE vaccine in children 5 to 11 years old. https://t.co/a1mSEgxNHQ pic.twitter.com/9xGfYEzFuy
– Pfizer Inc. (@pfizer) September 20, 2021
He stressed that “if we are serious about stopping this epidemic, we need to immunize 85-90% of the American population, and that means everyone, adults, teens or children.”
In the past few weeks, a quarter of recorded corona infection cases were children.
According to data from the American Academy of Pediatrics and the Center for Disease Control and Prevention (CDC), the past week saw a large number of injuries in children, and the number of cases requiring hospital treatment has increased, as the rate of child hospitalizations due to Covid-19 has reached around 311 cases. Day-to-day.
Currently, vaccines can be given to those who are over 12, while the vaccination rate for young Americans is still close to half, according to the “CDC.”
And Pfizer and Biotech announced on Monday that clinical test results showed their vaccine to be “safe” and gave a “strong” immune response in children aged 5 to 11, and they confirmed that they would seek approval for its use by regulators soon.
The two companies said in a statement that the vaccine will be given at a lower dose for this category, than that given to adults 12 years of age and older.
These are partial results of a study of 4,500 children aged 6 months to 11 years in the United States, Finland, Poland and Spain.
Pharmaceutical company Pfizer planned to seek approval from the US Food and Drug Administration “FDA” to be able to administer the vaccine against the emerging corona virus to children between 6 months and 5 years of age in November.
According to a document presented by the company at a health conference, it planned to seek permission to use the vaccine for children between the ages of 5 and 11 in early October.
“Since July, pediatric cases of COVID-19 have increased by nearly 240% in the United States, highlighting the public health need for vaccination,” said Albert Burla, CEO of Pfizer, in a Press release.
The two companies’ vaccine, called Kommernati, has already been approved for use in children aged 12 and over in many countries, including the United States.
Children in the five to 11 year age group will receive two doses equivalent to one-third of what was given to people 12 years of age and older.
The Corona virus has killed around 4.7 million people worldwide since the end of December 2019, according to a census carried out by Agence France-Presse.
And data released Monday by Johns Hopkins University indicated that the Corona virus has claimed more lives in the United States than the Spanish flu a century ago.
According to the latest report released by the university, more than 675,000 people infected with the Corona virus in the United States have died since the pandemic began in early 2020.
According to historians and the American Centers for Disease Prevention and Control, the Spanish flu that struck mankind in 1918-1919 claimed the lives of at least 50 million people around the world, but unlike Covid-19 , the Spanish flu pandemic has killed in particular the age groups that are supposed to be healthy, including children under 5 and those aged 20 to 40.
[ad_2]
Source link
